» Articles » PMID: 23858392

Prevalence and Perceived Financial Costs of Marijuana Versus Tobacco Use Among Urban Low-Income Pregnant Women

Overview
Date 2013 Jul 17
PMID 23858392
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the relative prevalence of marijuana and tobacco use among low-income post-partum women, using self-report, urine, and hair testing data; and to further explore perceptions of the substances among postpartum women by evaluating perceived risk and monetary cost of prenatal marijuana versus tobacco use.

Methods: Data from two studies were available for a total of 100 (Study 1) and 50 (Study 2) low-income, primarily African-American post-partum women. Study 1 participants completed brief self-report measures of substance use as well as urine and hair samples; study 2 participants completed a brief opinion survey regarding the risks and monetary costs of prenatal marijuana use.

Results: In Study 1, the self-reported prevalence of any tobacco or marijuana use in the past three months was 17% and 11%, respectively. However, objectively-defined marijuana use was more prevalent than self-reported tobacco use: 14% tested positive for marijuana by urinalysis, and 28% by hair analysis. Study 2 participants were more likely to believe that there is a safe level of marijuana use during pregnancy, and nearly half believed that using marijuana during pregnancy was less expensive than smoking cigarettes.

Conclusion: Marijuana use may be as or more prevalent than tobacco use among low-income, African-American pregnant women. These findings may in part be attributable to perceptions of roughly equivalent cost and the lack of a clear public health message regarding prenatal marijuana use, combined with growing pro-marijuana advocacy. A broader public health response to address prenatal marijuana use, along with other substances of abuse, is needed.

Citing Articles

Emerging trends in cannabis administration for women with chronic pain.

Cameron E, Jacquin K Mental Health Sci. 2025; 2(4.

PMID: 39816373 PMC: 11735029. DOI: 10.1002/mhs2.88.


Potentially modifiable risk and protective factors affecting mental and emotional wellness in pregnancy.

Wohrer F, Ngo H, DiDomenico J, Ma X, Roberts M, Bakhireva L Front Hum Neurosci. 2024; 18:1323297.

PMID: 38445095 PMC: 10912531. DOI: 10.3389/fnhum.2024.1323297.


Cannabidiol Exposure During Rat Pregnancy Leads to Labyrinth-Specific Vascular Defects in the Placenta and Reduced Fetal Growth.

Allen S, Natale B, Ejeckam A, Lee K, Hardy D, Natale D Cannabis Cannabinoid Res. 2024; 9(3):766-780.

PMID: 38364116 PMC: 11304342. DOI: 10.1089/can.2023.0166.


Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013-2019.

Kobernik E, Ford N, Levecke M, Galang R, Hoots B, Roehler D Subst Use Misuse. 2023; 59(5):690-698.

PMID: 38132561 PMC: 11000143. DOI: 10.1080/10826084.2023.2294974.


Cannabis and Pregnancy: A Review.

Hayer S, Mandelbaum A, Watch L, Ryan K, Hedges M, Manuzak J Obstet Gynecol Surv. 2023; 78(7):411-428.

PMID: 37480292 PMC: 10372687. DOI: 10.1097/OGX.0000000000001159.


References
1.
Murphy D, Durako S, Muenz L, Wilson C . Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis. Am J Epidemiol. 2000; 152(9):805-13. DOI: 10.1093/aje/152.9.805. View

2.
Gray T, Eiden R, Leonard K, Connors G, Shisler S, Huestis M . Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem. 2010; 56(9):1442-50. PMC: 3163087. DOI: 10.1373/clinchem.2010.147876. View

3.
Fendrich M, Johnson T, Sudman S, Wislar J, Spiehler V . Validity of drug use reporting in a high-risk community sample: a comparison of cocaine and heroin survey reports with hair tests. Am J Epidemiol. 1999; 149(10):955-62. DOI: 10.1093/oxfordjournals.aje.a009740. View

4.
Moore D, Turner J, Parrott A, Goodwin J, Fulton S, Min M . During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J Psychopharmacol. 2009; 24(9):1403-10. PMC: 3564500. DOI: 10.1177/0269881109348165. View

5.
Moolchan E, Zimmerman D, Sehnert S, Zimmerman D, Huestis M, Epstein D . Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Subst Use Misuse. 2005; 40(2):231-40. DOI: 10.1081/ja-200048461. View